Hypoxia-inducible factor prolyl hydroxylase inhibitor-induced thrombosis leading to transcatheter aortic valve dysfunction: a case report
This is the first report on a successful treatment of TAVR thrombosis formation associated with HIF-PH inhibitor use. When treating renal anaemia in patients undergoing TAVR, care should be taken to avoid rapid anaemia resolution and valve thrombosis development.
Authors
- Tatsuhiko Komiya (ORCID: https://orcid.org/0000-0003-3807-6724)
- Akihiro Ikuta (ORCID: https://orcid.org/0000-0001-7000-841X)
- Yasushi Fuku (ORCID: https://orcid.org/0000-0001-6047-8653)
- Kazushige Kadota (ORCID: https://orcid.org/0000-0003-2845-9561)
- Shunsuke Matsushita (ORCID: https://orcid.org/0000-0002-7870-0897)
Institutions
- Kurashiki Central Hospital (JP)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1093/ehjcr/ytae658
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Abbott Fund
- Edwards Lifesciences
- Medtronic